TY - JOUR
T1 - Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014
AU - Slavin, M.A.
AU - Thursky, K.A.
AU - Worth, L.J.
AU - Chang, C.C.
AU - Morrissey, C.O.
AU - Blyth, Christopher. C.
AU - Chen, S.C.
AU - Szer, J.
PY - 2014
Y1 - 2014
N2 - © 2014 Royal Australasian College of Physicians. This article introduces the second revision of the Australian andNewZealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting. The current update occurs within the context of a growing population at risk of invasive fungal disease, improved understanding of risk factors, availability of new diagnostic tests, a much-expanded evidence base and changing clinical paradigms. Here, we provide an overview of the history and purpose of the guidelines, including changes in scope since the last clinical update was published in 2008. The process for development, and for enabling review of draft recommendations by end-users and other relevant stakeholders, is described. The approach to assigning levels of evidence and grades of recommendation is also provided, along with a comparison to international grading systems.
AB - © 2014 Royal Australasian College of Physicians. This article introduces the second revision of the Australian andNewZealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting. The current update occurs within the context of a growing population at risk of invasive fungal disease, improved understanding of risk factors, availability of new diagnostic tests, a much-expanded evidence base and changing clinical paradigms. Here, we provide an overview of the history and purpose of the guidelines, including changes in scope since the last clinical update was published in 2008. The process for development, and for enabling review of draft recommendations by end-users and other relevant stakeholders, is described. The approach to assigning levels of evidence and grades of recommendation is also provided, along with a comparison to international grading systems.
U2 - 10.1111/imj.12593
DO - 10.1111/imj.12593
M3 - Review article
C2 - 25482739
VL - 44
SP - 1267
EP - 1276
JO - Internal Medicine Journal (Print)
JF - Internal Medicine Journal (Print)
SN - 1444-0903
IS - 12
ER -